Meek IL - Search Results

1

Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled Trial.

Ghiti Moghadam M, Vonkeman HE, Ten Klooster PM, Tekstra J, van Schaardenburg D, Starmans-Kool M, Brouwer E, Bos R, Lems WF, Colin EM, Allaart CF, Meek IL, Landewé R, Bernelot Moens HJ, van Riel PL, van de Laar MA, Jansen TL; Dutch National POET Collaboration. Ghiti Moghadam M, et al. Among authors: meek il. Arthritis Rheumatol. 2016 Aug;68(8):1810-7. doi: 10.1002/art.39626. Arthritis Rheumatol. 2016. PMID: 26866428 Clinical Trial.

2

Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin.

Vonkeman H, Meek I, van de Laar M. Vonkeman H, et al. Drug Healthc Patient Saf. 2010;2:191-204. doi: 10.2147/DHPS.S7206. Epub 2010 Oct 6. Drug Healthc Patient Saf. 2010. PMID: 21701631 Free PMC article.

3

Increased cardiovascular risk factors in different rheumatic diseases compared with the general population.

Meek IL, Picavet HS, Vonkeman HE, Verschuren WM, van de Laar MA. Meek IL, et al. Rheumatology (Oxford). 2013 Jan;52(1):210-6. doi: 10.1093/rheumatology/kes194. Epub 2012 Jul 30. Rheumatology (Oxford). 2013. PMID: 22847678

4

Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex vivo, serial placebo-controlled serial crossover study.

Meek IL, Vonkeman HE, Kasemier J, Movig KL, van de Laar MA. Meek IL, et al. Eur J Clin Pharmacol. 2013 Mar;69(3):365-71. doi: 10.1007/s00228-012-1370-y. Epub 2012 Aug 14. Eur J Clin Pharmacol. 2013. PMID: 22890587 Clinical Trial.

5

Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature.

Meek IL, Vonkeman HE, van de Laar MA. Meek IL, et al. BMC Musculoskelet Disord. 2014 Apr 29;15:142. doi: 10.1186/1471-2474-15-142. BMC Musculoskelet Disord. 2014. PMID: 24779371 Free PMC article. Review.

6

Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohort.

Meek IL, Vonkeman HE, van de Laar MA. Meek IL, et al. BMC Musculoskelet Disord. 2014 May 23;15:174. doi: 10.1186/1471-2474-15-174. BMC Musculoskelet Disord. 2014. PMID: 24886363 Free PMC article.

7

Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks.

Meek IL, Van de Laar MA, E Vonkeman H. Meek IL, et al. Pharmaceuticals (Basel). 2010 Jul 7;3(7):2146-2162. doi: 10.3390/ph3072146. Pharmaceuticals (Basel). 2010. PMID: 27713346 Free PMC article. Review.

8

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.

Crowson CS, Rollefstad S, Ikdahl E, Kitas GD, van Riel PLCM, Gabriel SE, Matteson EL, Kvien TK, Douglas K, Sandoo A, Arts E, Wållberg-Jonsson S, Innala L, Karpouzas G, Dessein PH, Tsang L, El-Gabalawy H, Hitchon C, Ramos VP, Yáñez IC, Sfikakis PP, Zampeli E, Gonzalez-Gay MA, Corrales A, Laar MV, Vonkeman HE, Meek I, Semb AG; A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA). Crowson CS, et al. Ann Rheum Dis. 2018 Jan;77(1):48-54. doi: 10.1136/annrheumdis-2017-211735. Epub 2017 Sep 6. Ann Rheum Dis. 2018. PMID: 28877868 Free PMC article.

9

Efficacy of a Web-Based Self-Management Enhancing Program for Patients with Rheumatoid Arthritis: Explorative Randomized Controlled Trial.

Zuidema R, van Dulmen S, Nijhuis-van der Sanden M, Meek I, van den Ende C, Fransen J, van Gaal B. Zuidema R, et al. J Med Internet Res. 2019 Apr 30;21(4):e12463. doi: 10.2196/12463. J Med Internet Res. 2019. PMID: 31038461 Free PMC article. Clinical Trial.

10

The added value of predictive biomarkers in treat-to-target strategies for rheumatoid arthritis patients: a conceptual modelling study.

Wientjes MHM, Ulijn E, Kievit W, Landewé RBM, Meek I, den Broeder N, van Herwaarden N, van den Bemt BJF, Verhoef LM, den Broeder AA. Wientjes MHM, et al. Rheumatology (Oxford). 2023 Aug 1;62(8):2700-2706. doi: 10.1093/rheumatology/keac709. Rheumatology (Oxford). 2023. PMID: 36538875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters